{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:00:24Z","timestamp":1717444824035},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00210-023-02927-2","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T08:02:07Z","timestamp":1704441727000},"page":"3829-3855","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Remdesivir: treatment of COVID-19 in special populations"],"prefix":"10.1007","volume":"397","author":[{"given":"Emad","family":"Molaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Molaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Wallace","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"2927_CR1","unstructured":"(2022) Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. The Lancet 399: 1941\u20131953"},{"key":"2927_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104808","volume":"156","author":"F Abedi","year":"2020","unstructured":"Abedi F, Rezaee R, Karimi G (2020) Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19). Pharmacol Res 156:104808","journal-title":"Pharmacol Res"},{"key":"2927_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/15384101.2020.1867792","volume":"20","author":"F Abedi","year":"2021","unstructured":"Abedi F, Rezaee R, Hayes AW, Nasiripour S, Karimi G (2021) MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? Cell Cycle 20:143\u2013153","journal-title":"Cell Cycle"},{"key":"2927_CR4","doi-asserted-by":"crossref","unstructured":"Ackley TW, McManus D, Topal JE, Cicali B, Shah S (2021) A valid warning or clinical lore: an evaluation of safety outcomes of remdesivir in patients with impaired renal function from a multicenter matched cohort. Antimicrob Agents Chemother 65:e02290\u201320","DOI":"10.1128\/AAC.02290-20"},{"key":"2927_CR5","unstructured":"(ACOG) ACoOaG (2022) COVID-19 FAQs for obstetricians-gynecologists,obstetrics., https:\/\/www.acog.org\/clinical-information\/physician-faqs\/covid-19-faqs-for-ob-gyns-obstetrics."},{"key":"2927_CR6","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1681\/ASN.2020050589","volume":"31","author":"ML Adamsick","year":"2020","unstructured":"Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME (2020) Remdesivir in patients with acute or chronic kidney disease and COVID-19. J Am Soc Nephrol 31:1384\u20131386","journal-title":"J Am Soc Nephrol"},{"key":"2927_CR7","unstructured":"Adarsh Bhimraj RLM, ** Amy Hirsch Shumaker, Lindsey Baden, Vincent Chi-Chung Cheng, Kathryn M. Edwards, Jason C. Gallagher, Rajesh T. Gandhi, William J. Muller, Mari M. Nakamura, John C. O\u2019Horo, Robert W. Shafer, Shmuel Shoham, M. Hassan Murad,** Reem A. Mustafa,** Shahnaz Sultan,** Yngve Falck-Ytter** (2023) IDSA Guidelines on the treatment and management of patients with COVID-19. IDSA"},{"key":"2927_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.29256","volume":"3","author":"EH Adhikari","year":"2020","unstructured":"Adhikari EH, Moreno W, Zofkie AC, MacDonald L, McIntire DD, Collins RRJ, Spong CY (2020) Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus 2 infection. JAMA Netw Open 3:e2029256","journal-title":"JAMA Netw Open"},{"key":"2927_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104899","volume":"158","author":"S Antinori","year":"2020","unstructured":"Antinori S, Cossu MV, Ridolfo AL, Rech R, Bonazzetti C, Pagani G, Gubertini G, Coen M, Magni C, Castelli A, Borghi B, Colombo R, Giorgi R, Angeli E, Mileto D, Milazzo L, Vimercati S, Pellicciotta M, Corbellino M, Torre A, Rusconi S, Oreni L, Gismondo MR, Giacomelli A, Meroni L, Rizzardini G, Galli M (2020) Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res 158:104899","journal-title":"Pharmacol Res"},{"key":"2927_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh M-d, Ruiz-Palacios GM, Benfield T, F\u00e4tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC (2020a) Remdesivir for the treatment of Covid-19 \u2014 final report. N Engl J Med 383:1813\u20131826","journal-title":"N Engl J Med"},{"key":"2927_CR11","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F\u00e4tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC (2020b) Remdesivir for the treatment of Covid-19\u2014final report. N Engl J Med 383:1813\u20131826","journal-title":"N Engl J Med"},{"key":"2927_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2147\/CIA.S313028","volume":"16","author":"E Biancalana","year":"2021","unstructured":"Biancalana E, Chiriac\u00f2 M, Sciarrone P, Mengozzi A, Mechelli S, Taddei S, Solini A (2021) Remdesivir, Renal function and short-term clinical outcomes in elderly COVID-19 pneumonia patients: a single-centre study. Clin Interv Aging 16:1037\u20131046","journal-title":"Clin Interv Aging"},{"key":"2927_CR13","doi-asserted-by":"publisher","first-page":"10426","DOI":"10.3389\/bjbs.2022.10426","volume":"79","author":"AD Blann","year":"2022","unstructured":"Blann AD, Heitmar R (2022) SARS-CoV-2 and COVID-19: A Narrative Review. Br J Biomed Sci 79:10426","journal-title":"Br J Biomed Sci"},{"key":"2927_CR14","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1002\/jmv.27768","volume":"94","author":"L Boglione","year":"2022","unstructured":"Boglione L, Dodaro V, Meli G, Rostagno R, Poletti F, Moglia R, Bianchi B, Esposito M, Borr\u00e8 S (2022) Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: a case-control study. J Med Virol 94:3653\u20133660","journal-title":"J Med Virol"},{"key":"2927_CR15","doi-asserted-by":"publisher","first-page":"e3996","DOI":"10.1093\/cid\/ciaa1466","volume":"73","author":"RM Burwick","year":"2021","unstructured":"Burwick RM, Yawetz S, Stephenson KE, Collier AY, Sen P, Blackburn BG, Kojic EM, Hirshberg A, Suarez JF, Sobieszczyk ME, Marks KM, Mazur S, Big C, Manuel O, Morlin G, Rose SJ, Naqvi M, Goldfarb IT, DeZure A, Telep L, Tan SK, Zhao Y, Hahambis T, Hindman J, Chokkalingam AP, Carter C, Das M, Osinusi AO, Brainard DM, Varughese TA, Kovalenko O, Sims MD, Desai S, Swamy G, Sheffield JS, Zash R, Short WR (2021) Compassionate use of remdesivir in pregnant women with severe coronavirus disease 2019. Clin Infect Dis 73:e3996\u2013e4004","journal-title":"Clin Infect Dis"},{"key":"2927_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nefroe.2022.07.006","volume":"42","author":"J Cacho","year":"2022","unstructured":"Cacho J, Burgos E, Molina M, Villegas A, P\u00e9rez M, Ca\u00f1as L, Taco O, Juega J, Lauzurica R (2022) Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia. Nefrologia (engl Ed) 42:311\u2013317","journal-title":"Nefrologia (engl Ed)"},{"key":"2927_CR17","doi-asserted-by":"crossref","unstructured":"Chavda VP, Teli D, Balar PC, Vaghela D, Solanki HK, Vaishnav A, Vora L (2023) Potential anti-SARS-CoV-2 prodrugs activated by phosphorylation and their role in the aged population. Molecules 28:2332","DOI":"10.3390\/molecules28052332"},{"key":"2927_CR18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cts.13194","volume":"15","author":"PG Choe","year":"2022","unstructured":"Choe PG, Jeong SI, Kang CK, Yang L, Lee S, Cho JY, Han SS, Kim DK, Lee SM, Park WB, Oh MD, Kim NJ (2022) Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS-441524 in patients with COVID-19: a limited case series. Clin Transl Sci 15:732\u2013740","journal-title":"Clin Transl Sci"},{"key":"2927_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/jpids\/piab029","volume":"10","author":"EJ Chow","year":"2021","unstructured":"Chow EJ, Maust B, Kazmier KM, Stokes C (2021) Sinus bradycardia in a pediatric patient treated with remdesivir for acute coronavirus disease 2019: a case report and a review of the literature. J Pediatric Infect Dis Soc 10:926\u2013929","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2927_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijid.2022.05.001","volume":"121","author":"M Colaneri","year":"2022","unstructured":"Colaneri M, Amarasinghe N, Rezzonico L, Pieri TC, Segalini E, Sambo M, Roda S, Meloni F, Gregorini M, Rampino T, Pelenghi S, Ricciardi A, Bruno R (2022) Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy. Int J Infect Dis 121:157\u2013160","journal-title":"Int J Infect Dis"},{"key":"2927_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/20009666.2020.1857510","volume":"11","author":"R Dande","year":"2021","unstructured":"Dande R, Qureshi A, Persaud K, Puri C, Zulfiqar S, Awasthi S (2021) Remdesivir in a pregnant patient with COVID-19 pneumonia. J Community Hosp Intern Med Perspect 11:103\u2013106","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2927_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/jac\/dkaa472","volume":"76","author":"MR Davis","year":"2021","unstructured":"Davis MR, Pham CU, Cies JJ (2021) Remdesivir and GS-441524 plasma concentrations in patients with end-stage renal disease on haemodialysis. J Antimicrob Chemother 76:822\u2013825","journal-title":"J Antimicrob Chemother"},{"key":"2927_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/AOG.0000000000004734","volume":"139","author":"J Eid","year":"2022","unstructured":"Eid J, Abdelwahab M, Colburn N, Day S, Cackovic M, Rood KM, Costantine MM (2022) Early administration of remdesivir and intensive care unit admission in hospitalized pregnant individuals with coronavirus disease 2019 (COVID-19). Obstet Gynecol 139:619\u2013621","journal-title":"Obstet Gynecol"},{"key":"2927_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/FTD.0000000000000761","volume":"42","author":"L Elens","year":"2020","unstructured":"Elens L, Langman LJ, Hesselink DA, Bergan S, Moes D, Molinaro M, Venkataramanan R, Lemaitre F (2020) Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions. Ther Drug Monit 42:360\u2013368","journal-title":"Ther Drug Monit"},{"key":"2927_CR25","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.transproceed.2022.10.043","volume":"54","author":"D Fesu","year":"2022","unstructured":"Fesu D, Bohacs A, Hidvegi E, Matics Z, Polivka L, Horvath P, Czaller I, Sutto Z, Eszes N, Vincze K, Muller V (2022) Remdesivir in solid organ recipients for COVID-19 pneumonia. Transplant Proc 54:2567\u20132569","journal-title":"Transplant Proc"},{"key":"2927_CR26","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/cid\/ciab712","volume":"74","author":"J Fintzi","year":"2022","unstructured":"Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK (2022) Deconstructing the treatment effect of remdesivir in the adaptive coronavirus disease 2019 (COVID-19) treatment trial-1: implications for critical care resource utilization. Clin Infect Dis 74:2209\u20132217","journal-title":"Clin Infect Dis"},{"key":"2927_CR27","doi-asserted-by":"crossref","unstructured":"Frauenfelder C, Brierley J, Whittaker E, Perucca G, Bamford A (2020) Infant with SARS-CoV-2 infection causing severe lung disease treated with remdesivir. Pediatrics 146:e20201701","DOI":"10.1542\/peds.2020-1701"},{"key":"2927_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.37201\/req\/018.2021","volume":"34","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, Meira F, C\u00f3zar-Llist\u00f3 A, Due\u00f1as G, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, Cardozo C, Hernandez-Meneses M, Alonso-Navarro R, Rico V, Ag\u00fcero D, Bodro M, Morata L, Jordan C, Lopera C, Ambrosioni J, Segui F, Grafia N, Castro P, Garc\u00eda F, Mensa J, Mart\u00ednez JA, Sanjuan G, Soriano A (2021) Real-life use of remdesivir in hospitalized patients with COVID-19. Rev Esp Quimioter 34:136\u2013140","journal-title":"Rev Esp Quimioter"},{"key":"2927_CR29","doi-asserted-by":"crossref","unstructured":"Goldman DL, Aldrich ML, Hagmann SHF, Bamford A, Camacho-Gonzalez A, Lapadula G, Lee P, Bonfanti P, Carter CC, Zhao Y, Telep L, Pikora C, Naik S, Marshall N, Katsarolis I, Das M, DeZure A, Desai P, Cao H, Chokkalingam AP, Osinusi A, Brainard DM, M\u00e9ndez-Echevarr\u00eda A (2021) Compassionate use of remdesivir in children with severe COVID-19. Pediatrics 147:e2020047803","DOI":"10.1542\/peds.2020-047803"},{"key":"2927_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, Ryan P, Nielsen BU, Brown M, Hidalgo A, Sachdeva Y, Mittal S, Osiyemi O, Skarbinski J, Juneja K, Hyland RH, Osinusi A, Chen S, Camus G, Abdelghany M, Davies S, Behenna-Renton N, Duff F, Marty FM, Katz MJ, Ginde AA, Brown SM, Schiffer JT, Hill JA (2022) Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med 386:305\u2013315","journal-title":"N Engl J Med"},{"key":"2927_CR31","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1080\/14767058.2022.2041595","volume":"35","author":"R Gutierrez","year":"2022","unstructured":"Gutierrez R, Mendez-Figueroa H, Biebighauser JG, Bhalwal A, Pineles BL, Chauhan SP (2022) Remdesivir use in pregnancy during the SARS-CoV-2 pandemic. J Matern Fetal Neonatal Med 35:9445\u20139451","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2927_CR32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.ekir.2023.04.028","volume":"8","author":"E Habeeb","year":"2023","unstructured":"Habeeb E, Gabardi S, Townsend K, Kim M (2023) Potential effects of remdesivir on tacrolimus exposure in transplant recipients with COVID-19 infection. Kidney Int Rep 8:1315\u20131322","journal-title":"Kidney Int Rep"},{"key":"2927_CR33","unstructured":"Health NIo (2023) Coronavirus disease 2019 (COVID-19) treatment guidelines"},{"key":"2927_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jhin.2022.08.001","volume":"129","author":"R Herz-Roiphe","year":"2022","unstructured":"Herz-Roiphe R, Kim AY, Kaimal AJ, Goldfarb IT (2022) Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge. J Hosp Infect 129:38\u201340","journal-title":"J Hosp Infect"},{"key":"2927_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/jpids\/piaa165","volume":"10","author":"AJ Hopwood","year":"2021","unstructured":"Hopwood AJ, Jordan-Villegas A, Gutierrez LD, Cowart MC, Vega-Montalvo W, Cheung WL, McMahan MJ, Gomez MR, Laham FR (2021) Severe acute respiratory syndrome coronavirus-2 pneumonia in a newborn treated with remdesivir and coronavirus disease 2019 convalescent plasma. J Pediatric Infect Dis Soc 10:691\u2013694","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2927_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ajog.2020.08.001","volume":"223","author":"I Igbinosa","year":"2020","unstructured":"Igbinosa I, Miller S, Bianco K, Nelson J, Kappagoda S, Blackburn BG, Grant P, Subramanian A, Lyell DJ, El-Sayed YY, Aziz N (2020) Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019. Am J Obstet Gynecol 223:768\u2013770","journal-title":"Am J Obstet Gynecol"},{"key":"2927_CR37","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e203","volume":"36","author":"YH Jo","year":"2021","unstructured":"Jo YH, Hwang Y, Choi SH (2021) A case report for severe covid-19 in a 9-year-old child treated with remdesivir and dexamethasone. J Korean Med Sci 36:e203","journal-title":"J Korean Med Sci"},{"key":"2927_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/jac\/dkab311","volume":"77","author":"SCJ Jorgensen","year":"2021","unstructured":"Jorgensen SCJ, Davis MR, Lapinsky SE (2021) A review of remdesivir for COVID-19 in pregnancy and lactation. J Antimicrob Chemother 77:24\u201330","journal-title":"J Antimicrob Chemother"},{"key":"2927_CR39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s40266-021-00908-9","volume":"38","author":"O Kanai","year":"2021","unstructured":"Kanai O, Fujita K, Nanba K, Esaka N, Hata H, Seta K, Yasoda A, Odagaki T, Mio T (2021) Safety of remdesivir for patients 80 years of age or older with coronavirus disease 2019 (COVID-19). Drugs Aging 38:1067\u20131074","journal-title":"Drugs Aging"},{"key":"2927_CR40","volume":"92","author":"A La Tessa","year":"2021","unstructured":"La Tessa A, Motisi MA, Marseglia GL, Cardinale F, Licari A, Manti S, Tosca M, Del Giudice MM, De Filippo M, Galli L, Chiappini E (2021) Use of remdesivir in children with COVID-19 infection: a quick narrative review. Acta Biomed 92:e2021524","journal-title":"Acta Biomed"},{"key":"2927_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/cid\/ciaa444","volume":"71","author":"S LaCourse","year":"2020","unstructured":"LaCourse S, John-Stewart G, Adams Waldorf KM (2020) Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials. Clin Infect Dis 71:879\u2013881","journal-title":"Clin Infect Dis"},{"key":"2927_CR42","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1002\/jmv.26986","volume":"93","author":"T Lampejo","year":"2021","unstructured":"Lampejo T (2021) Remdesivir for the treatment of COVID-19 in pregnancy. J Med Virol 93:4114\u20134119","journal-title":"J Med Virol"},{"key":"2927_CR43","doi-asserted-by":"crossref","unstructured":"Lapadula G, Bernasconi DP, Bellani G, Soria A, Rona R, Bombino M, Avalli L, Rondelli E, Cortinovis B, Colombo E, Valsecchi MG, Migliorino GM, Bonfanti P, Foti G, Group R-RS (2020b) Remdesivir use in patients requiring mechanical ventilation due to COVID-19. Open Forum Infectious Diseases 7","DOI":"10.1093\/ofid\/ofaa481"},{"key":"2927_CR44","doi-asserted-by":"crossref","unstructured":"Lapadula G, Bernasconi DP, Bellani G, Soria A, Rona R, Bombino M, Avalli L, Rondelli E, Cortinovis B, Colombo E, Valsecchi MG, Migliorino GM, Bonfanti P, Foti G (2020a) Remdesivir use in patients requiring mechanical ventilation due to COVID-19. Open Forum Infect Dis 7: ofaa481","DOI":"10.1093\/ofid\/ofaa481"},{"key":"2927_CR45","first-page":"926","volume":"120","author":"S Lee","year":"2020","unstructured":"Lee S, Santarelli A, Caine K, Schritter S, Dietrich T, Ashurst J (2020) Remdesivir for the treatment of severe COVID-19: a community hospital\u2019s experience. J Am Osteopath Assoc 120:926\u2013933","journal-title":"J Am Osteopath Assoc"},{"key":"2927_CR46","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e13","volume":"37","author":"H Lee","year":"2022","unstructured":"Lee H, Choi S, Park JY, Jo DS, Choi UY, Lee H, Jung YT, Chung IH, Choe YJ, Kim JY, Park YJ, Choi EH (2022) Analysis of critical COVID-19 cases among children in Korea. J Korean Med Sci 37:e13","journal-title":"J Korean Med Sci"},{"key":"2927_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/0018578721999804","volume":"58","author":"TL Levien","year":"2023","unstructured":"Levien TL, Baker DE (2023) Remdesivir. Hosp Pharm 58:420\u2013430","journal-title":"Hosp Pharm"},{"key":"2927_CR48","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00431-022-04615-4","volume":"181","author":"E Liu","year":"2022","unstructured":"Liu E, Smyth RL, Li Q, Qaseem A, Florez ID, Mathew JL, Amer YS, Estill J, Lu Q, Fu Z, Lu X, Chan ES, Schwarze J, Wong GW, Fukuoka T, Ahn HS, Lee MS, Nurdiati D, Cao B, Tu W, Qian Y, Zhao S, Dong X, Luo X, Chen Z, Li G, Zhang X, Zhao X, Xu H, Xu F, Shi Y, Zhao R, Zhao Y, Lei J, Zheng X, Wang M, Yang S, Feng X, Wu L, He Z, Liu S, Wang Q, Song Y, Luo Z, Zhou Q, Guyatt G, Chen Y, Li Q (2022) Guidelines for the prevention and management of children and adolescents with COVID-19. Eur J Pediatr 181:4019\u20134037","journal-title":"Eur J Pediatr"},{"key":"2927_CR49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/psp4.12900","volume":"12","author":"XI Liu","year":"2023","unstructured":"Liu XI, Dallmann A, Brooks K, Best BM, Clarke DF, Mirochnick M, van den Anker JN, Capparelli EV, Momper JD (2023) Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19. CPT Pharmacometrics Syst Pharmacol 12:148\u2013153","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"2927_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nefroe.2020.03.017","volume":"40","author":"V L\u00f3pez","year":"2020","unstructured":"L\u00f3pez V, V\u00e1zquez T, Alonso-Titos J, Cabello M, Alonso A, Beneyto I, Crespo M, D\u00edaz-Corte C, Franco A, Gonz\u00e1lez-Roncero F, Guti\u00e9rrez E, Guirado L, Jim\u00e9nez C, Jironda C, Lauzurica R, Llorente S, Mazuecos A, Paul J, Rodr\u00edguez-Benot A, Ruiz JC, S\u00e1nchez-Fructuoso A, Sola E, Torregrosa V, Z\u00e1rraga S, Hern\u00e1ndez D (2020) Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients. Nefrologia (engl Ed) 40:265\u2013271","journal-title":"Nefrologia (engl Ed)"},{"key":"2927_CR51","doi-asserted-by":"crossref","unstructured":"Maldarelli GA, Savage M, Mazur S, Oxford-Horrey C, Salvatore M, Marks KM (2020) Remdesivir treatment for severe COVID-19 in third-trimester pregnancy: case report and management discussion. Open Forum Infect Dis 7: ofaa345","DOI":"10.1093\/ofid\/ofaa345"},{"key":"2927_CR52","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1248\/bpb.b22-00470","volume":"45","author":"S Manabe","year":"2022","unstructured":"Manabe S, Mizuno S, Jinda T, Kasai M (2022) Safety of remdesivir in 20 children with COVID-19\u2014case series. Biol Pharm Bull 45:1853\u20131856","journal-title":"Biol Pharm Bull"},{"key":"2927_CR53","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00431-020-03876-1","volume":"180","author":"A M\u00e9ndez-Echevarr\u00eda","year":"2021","unstructured":"M\u00e9ndez-Echevarr\u00eda A, P\u00e9rez-Mart\u00ednez A, Gonzalez Del Valle L, Ara MF, Melendo S, Ruiz de Valbuena M, Vazquez-Martinez JL, Morales-Mart\u00ednez A, Remesal A, S\u00e1ndor-Bajusz KA, Caba\u00f1as F, Calvo C (2021) Compassionate use of remdesivir in children with COVID-19. Eur J Pediatr 180:1317\u20131322","journal-title":"Eur J Pediatr"},{"key":"2927_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13629","volume":"23","author":"HS Meshram","year":"2021","unstructured":"Meshram HS, Kute VB, Patel H, Banerjee S, Navadiya V, Desai S, Rizvi SJ, Mishra V, Chauhan S (2021) Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: a retrospective cohort from a developing nation. Transpl Infect Dis 23:e13629","journal-title":"Transpl Infect Dis"},{"key":"2927_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174527","volume":"911","author":"E Molaei","year":"2021","unstructured":"Molaei E, Molaei A, Hayes AW, Karimi G (2021) Resolvin D1, therapeutic target in acute respiratory distress syndrome. Eur J Pharmacol 911:174527","journal-title":"Eur J Pharmacol"},{"key":"2927_CR56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/AOG.0000000000004050","volume":"136","author":"M Naqvi","year":"2020","unstructured":"Naqvi M, Zakowski P, Glucksman L, Smithson S, Burwick RM (2020) Tocilizumab and remdesivir in a pregnant patient with coronavirus disease 2019 (COVID-19). Obstet Gynecol 136:1025\u20131029","journal-title":"Obstet Gynecol"},{"key":"2927_CR57","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1111\/bjh.17014","volume":"190","author":"K Orf","year":"2020","unstructured":"Orf K, Rogosic S, Dexter D, Ancliff P, Badle S, Brierley J, Cheng D, Dalton C, Dixon G, Du Pr\u00e9 P, Grandjean L, Ghorashian S, Mittal P, O\u2019Connor D, Pavasovic V, Rao A, Samarasinghe S, Vora A, Bamford A, Bartram J (2020) Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection. Br J Haematol 190:e274\u2013e276","journal-title":"Br J Haematol"},{"key":"2927_CR58","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/jac\/dkaa321","volume":"75","author":"Z Pasquini","year":"2020","unstructured":"Pasquini Z, Montalti R, Temperoni C, Canovari B, Mancini M, Tempesta M, Pimpini D, Zallocco N, Barchiesi F (2020) Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. J Antimicrob Chemother 75:3359\u20133365","journal-title":"J Antimicrob Chemother"},{"key":"2927_CR59","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/phar.2524","volume":"41","author":"BJ Peters","year":"2021","unstructured":"Peters BJ, Rabinstein AA, DuBrock HM (2021) Use of remdesivir in myasthenia gravis and COVID-19. Pharmacotherapy 41:546\u2013550","journal-title":"Pharmacotherapy"},{"key":"2927_CR60","doi-asserted-by":"crossref","unstructured":"Sabers AJ, Williams AL, Farley TM (2020) Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection. BMJ Case Rep 13","DOI":"10.1136\/bcr-2020-239210"},{"key":"2927_CR61","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1097\/INF.0000000000003081","volume":"40","author":"B Saikia","year":"2021","unstructured":"Saikia B, Tang J, Robinson S, Nichani S, Lawman KB, Katre M, Bandi S (2021) Neonates With SARS-CoV-2 infection and pulmonary disease safely treated with remdesivir. Pediatr Infect Dis J 40:e194\u2013e196","journal-title":"Pediatr Infect Dis J"},{"key":"2927_CR62","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1097\/INF.0000000000003504","volume":"41","author":"MA Sarhan","year":"2022","unstructured":"Sarhan MA, Casalino M, Paopongsawan P, Gryn D, Kulkarni T, Bitnun A, Gauda EB (2022) SARS-CoV-2 associated respiratory failure in a preterm infant and the outcome after remdesivir treatment. Pediatr Infect Dis J 41:e233\u2013e234","journal-title":"Pediatr Infect Dis J"},{"key":"2927_CR63","doi-asserted-by":"crossref","unstructured":"Seethapathy R, Zhao S, Long JD, Strohbehn IA, Sise ME (2022) A propensity score-matched observational study of remdesivir in patients with COVID-19 and severe kidney disease. Kidney360 3: 269\u2013278","DOI":"10.34067\/KID.0006152021"},{"key":"2927_CR64","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.4103\/1319-2442.338277","volume":"32","author":"A Shakir","year":"2021","unstructured":"Shakir A, Bhasin N, Swami R, Mehta K, Sinha S, Ali SS, Bansode J (2021) Renal and hepatic outcomes after remdesivir therapy in coronavirus disease-2019-positive patients with renal dysfunction at baseline or after starting therapy. Saudi J Kidney Dis Transpl 32:1034\u20131042","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2927_CR65","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311x00077721","volume":"37","author":"NAO Silva","year":"2021","unstructured":"Silva NAO, Zara A, Figueras A, Melo DO (2021) Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database. Cad Saude Publica 37:e00077721","journal-title":"Cad Saude Publica"},{"key":"2927_CR66","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/jac\/dkaa500","volume":"76","author":"F S\u00f6rgel","year":"2021","unstructured":"S\u00f6rgel F, Malin JJ, Hagmann H, Kinzig M, Bilal M, Eichenauer DA, Scherf-Clavel O, Simonis A, El Tabei L, Fuhr U, Rybniker J (2021) Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis. J Antimicrob Chemother 76:825\u2013827","journal-title":"J Antimicrob Chemother"},{"key":"2927_CR67","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ekir.2020.10.005","volume":"6","author":"S Thakare","year":"2021","unstructured":"Thakare S, Gandhi C, Modi T, Bose S, Deb S, Saxena N, Katyal A, Patil A, Patil S, Pajai A, Bajpai D, Jamale T (2021) Safety of remdesivir in patients with acute kidney injury or CKD. Kidney Int Rep 6:206\u2013210","journal-title":"Kidney Int Rep"},{"key":"2927_CR68","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/infdis\/jiab035","volume":"223","author":"JM Thiede","year":"2021","unstructured":"Thiede JM, Gress AR, Libby SD, Ronayne CE, Matchett WE, Noren B, Billings JL, Menachery VD, Langlois RA, Kline S, Bold TD (2021) Immune profiling to determine early disease trajectories associated with coronavirus disease 2019 mortality rate: a substudy from the ACTT-1 trial. J Infect Dis 223:1339\u20131344","journal-title":"J Infect Dis"},{"key":"2927_CR69","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/jac\/dkab076","volume":"76","author":"T Umemura","year":"2021","unstructured":"Umemura T, Nishikawa K, Mutoh Y, Sasano H, Kozaki K, Yamada T, Ichihara T (2021) Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child-Pugh class C. J Antimicrob Chemother 76:1947\u20131948","journal-title":"J Antimicrob Chemother"},{"key":"2927_CR70","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/08903344221076539","volume":"38","author":"YS Wada","year":"2022","unstructured":"Wada YS, Saito J, Hashii Y, Kishi T, Kobayashi M, Kamiya T, Mizuno K (2022) Remdesivir and human milk: a case study. J Hum Lact 38:248\u2013251","journal-title":"J Hum Lact"},{"key":"2927_CR71","first-page":"11","volume":"69","author":"S Waddankeri","year":"2021","unstructured":"Waddankeri S, Hesarur SS, Hiremath SS, Sangamesh A, Ar S, Raikod BP, Kinagi S, Biradar S, Belli B, Melkundi S, Singh G (2021) Clinical efficacy and safety of remdesivir among hospitalised adult patients with RT PCR confirmed COVID 19 requiring ICU care in Kalyana Karnataka. J Assoc Physicians India 69:11\u201312","journal-title":"J Assoc Physicians India"},{"key":"2927_CR72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/08850666211070521","volume":"37","author":"S Wang","year":"2022","unstructured":"Wang S, Huynh C, Islam S, Malone B, Masani N, Joseph D (2022a) Assessment of safety of remdesivir in Covid - 19 patients with estimated glomerular filtration rate (eGFR) < 30 ml\/min per 1.73 m^2. J Intensive Care Med 37:764\u2013768","journal-title":"J Intensive Care Med"},{"key":"2927_CR73","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00431-022-04388-w","volume":"181","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhao S, Tang Y, Wang Z, Shi Q, Dang X, Gan L, Peng S, Li W, Zhou Q, Li Q, Mafiana JJ, Cort\u00e9s RG, Luo Z, Liu E, Chen Y (2022b) Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review. Eur J Pediatr 181:2135\u20132146","journal-title":"Eur J Pediatr"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02927-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02927-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02927-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T09:08:09Z","timestamp":1716368889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02927-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2927"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02927-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and agreed to the final copy of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}